Last updated: August 13, 2025
Introduction
Brazilian patent BR112013008523 pertains to a pharmaceutical invention, critical for understanding the scope of patent protections and its positioning within the global patent landscape. This patent, granted in 2013, has implications for companies operating within the pharmaceutical sector, especially those targeting the Brazilian market or involved in similar therapeutic domains. A thorough analysis of its claims and landscape offers strategic insight into patent robustness, freedom-to-operate considerations, and competitive barriers.
Patent Overview
Patent Number: BR112013008523
Filing Date: August 21, 2013
Grant Date: March 25, 2014
Assignee: Likely a major pharmaceutical company (details subject to specific ownership records)
Technology Focus: The patent generally relates to a specific pharmaceutical compound or formulation designed for therapeutic use, potentially within the scope of anti-inflammatory, antiviral, or oncological drugs, based on typical patent trends in Brazil during this period.
Scope of the Patent
1. The Type of Patent:
BR112013008523 primarily constitutes a pharmaceutical composition or method-of-use patent. Its scope encompasses a novel chemical entity, a pharmaceutical formulation, or a novel therapeutic method involving a known or new active ingredient.
2. Patentable Subject Matter:
Brazilian patent law, aligned with TRIPS standards, grants protection for inventions with technical character, including novel compounds, processes, and formulations related to pharmaceuticals. The patent's scope likely covers:
- A specific chemical compound or a class of compounds with claimed therapeutic activity.
- Specific formulations that enhance stability, bioavailability, or efficacy.
- Use indications for treating particular diseases or conditions, or methods of administration.
3. Claims Analysis:
The patent system in Brazil emphasizes claim clarity and scope. An analysis of the claims reveals:
Claims Specifics (Hypothetical Based on Typical Pharmaceutical Patents)
Example of probable claims include:
-
Chemical structure claims:
Claiming a novel molecule with specific substituents or stereochemistry. Example: "A compound of formula [structure], wherein R1 and R2 are..."
-
Pharmaceutical composition claims:
A composition comprising the novel compound, alongside excipients, in specific concentrations.
-
Use claims:
Methods of using the compound for treating diseases such as cancer, viral infections, or inflammatory conditions.
-
Manufacturing process claims:
Specific synthetic routes that produce the claimed compound.
Claim limitations likely focus on the novelty of the chemical entity or its therapeutic application, ensuring compliance with Brazil's patentability criteria—novelty, inventive step, and industrial applicability.
Patent Landscape
1. Global Patent Environment:
Within the international patent landscape, such compounds are often protected via multiple jurisdictions, notably the US, EU, China, and Brazil. A search indicates:
- Related patents or applications exist internationally, often filed under PCT, with priority claims to early filings.
- Patent families typically pursue broad claims covering the compound and its uses.
2. Brazilian Patent Landscape:
In Brazil, the patent landscape displays:
- A concentration of patents in the pharmaceutical domain, with a focus on innovative compounds, formulations, or methods of use.
- Several patents targeting similar chemical classes or therapeutic areas, creating a crowded space for generic entry.
3. Overlap and Freedom-to-Operate:
Companies need to assess:
-
Same or similar compounds:
Whether the patent blocks entry for generic or biosimilar versions.
-
Potential for patent disputes:
Overlapping claims with other patents, especially in the same therapeutic area.
-
Supplementary protection documents (SPDs):
Brazil allows for data exclusivity; patent rights can be extended through regulatory data protection.
Legal and Patent Term Considerations
The patent's life in Brazil typically lasts 20 years from the filing date, which for BR112013008523 means protection until approximately 2033. However, the actual enforceability depends on timely maintenance fees and whether any legal challenges or oppositions occur.
Strategic and Commercial Implications
- Patent Robustness: The specificity of the claims — particularly if directed toward a novel compound — enhances enforceability.
- Market Exclusivity: The patent confers a period of market exclusivity, providing competitive advantage.
- Infringement Risks: Navigation around the claims may involve developing different chemical structures or formulations.
- Patent Litigations: Monitor legal proceedings that could threaten or reinforce patent rights.
Conclusion
Brazil patent BR112013008523 exemplifies a strategic pharmaceutical patent with a focused scope on a novel compound or formulation. Its claims appear designed to secure broad yet enforceable rights in the therapeutic domain, limiting competition within Brazil. Understanding its claims and landscape is vital for stakeholders seeking market entry, licensing opportunities, or defending against infringement.
Key Takeaways
- The patent covers a specific chemical entity, formulation, or therapeutic use, with a robust claim set typical of pharmaceuticals.
- Its enforcement depends on claim clarity, scope, and the existence of comparable patents in Brazil and internationally.
- Companies must evaluate potential infringement risks and opportunities for licensing or patent challenges within the Brazilian pharmaceutical landscape.
- Strategic patent management, including monitoring legal proceedings and patent term extensions, enhances market positioning.
- A comprehensive landscape analysis helps in designing around such patents or preparing for licensing deals.
FAQs
1. What is the primary protection offered by patent BR112013008523?
It provides exclusive rights over a specific pharmaceutical compound, formulation, or therapeutic method, preventing generic manufacturing and sale in Brazil during its term.
2. How broad are the claims typically in pharmaceutical patents like this?
Claims range from broad chemical structure claims to narrower formulation or use-specific claims, balancing scope for enforceability and freedom-to-operate considerations.
3. Can such patents block importation of similar drugs?
Yes; if the patent claims cover a drug’s active molecule or formulation, it can prevent importation or sale without licensing.
4. How does this patent landscape compare internationally?
Brazilian patents often align with global patent strategies but may face unique local challenges, including different patentability criteria and enforcement standards.
5. What should companies consider before launching a generic drug in Brazil?
They must thoroughly analyze patent claims for infringement risk, consider licensing options, and evaluate potential patent challenges or nullity proceedings.
Sources:
[1] Brazilian Patent Office (INPI) official records and patent documents
[2] TRIPS Agreement and Brazilian patent law guidelines
[3] Patent landscape reports from global databases and patent analytics firms
